The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation
Abstract
Background— Phase I clinical studies have demonstrated the feasibility of implanting autologous skeletal myoblasts in postinfarction scars. However, they have failed to determine whether this procedure was functionally effective and arrhythmogenic. Methods and Results— This multicenter, randomized, placebo-controlled, double-blind study included patients with left ventricular (LV) dysfunction (ejection fraction ≤35%), myocardial infarction, and indication for coronary surgery. Each patient received either cells grown from a skeletal muscle biopsy or a placebo solution injected in and around the scar. All patients received an implantable cardioverter-defibrillator. The primary efficacy end points were the 6-month changes in global and regional LV function assessed by echocardiography. The safety end points comprised a composite index of major cardiac adverse events and ventricular arrhythmias. Ninety-seven patients received myoblasts (400 or 800 million; n=33 and n=34, respectively) or the placebo (n=30). Myoblast transfer did not improve regional or global LV function beyond that seen in control patients. The absolute change in ejection fraction (median [interquartile range]) between 6 months and baseline was 4.4% (0.2; 7.3), 3.4% (−0.3; 12.4), and 5.2% (−4.4; 11.0) in the placebo, low-dose, and high-dose groups, respectively ( P =0.95). However, the high-dose cell group demonstrated a significant decrease in LV volumes compared with the placebo group. Despite a higher number of arrhythmic events in the myoblast-treated patients, the 6-month rates of major cardiac adverse events and of ventricular arrhythmias did not differ significantly between the pooled treatment and placebo groups. Conclusions— Myoblast injections combined with coronary surgery in patients with depressed LV function failed to improve echocardiographic heart function. The increased number of early postoperative arrhythmic events after myoblast transplantation, as well as the capability of high-dose injections to revert LV remodeling, warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Myoblast transplantation for heart failure
Menasché, P., Hagège, A. A., Scorsin, M., Pouzet, B., Desnos, M., Duboc, D., Schwartz, K., Vilquin, J.-T., & Marolleau, J.-P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03617-5 · Cited by 1,124
Self-citationYusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.575118 · Cited by 991
Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis
Abdel-Latif, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.989 · Cited by 880
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host
Léobon, B., Garcin, I., Menasché, P., Vilquin, J.-T., Audinat, E., & Charpak, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232447100 · Cited by 482
Self-citationDoughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S., & Sharpe, N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00012-0 · Cited by 422
Skeletal Muscle Stem Cells Do Not Transdifferentiate Into Cardiomyocytes After Cardiac Grafting
Reinecke, H., Poppa, V., & Murry, C. E. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1507 · Cited by 397
St John Sutton, M. G., Plappert, T., Hilpisch, K. E., Abraham, W. T., Hayes, D. L., & Chinchoy, E. (2006) · Circulation · doi:10.1161/circulationaha.104.520817 · Cited by 361
Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzeźniczak, J., Rozwadowska, N., & Kurpisz, M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.043 · Cited by 347
Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets
Memon, I. A., Sawa, Y., Fukushima, N., Matsumiya, G., Miyagawa, S., Taketani, S., Sakakida, S. K., Kondoh, H., Aleshin, A. N., Shimizu, T., et al. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.07.023 · Cited by 325
Dib, N., Michler, R. E., Pagani, F. D., Wright, S., Kereiakes, D. J., Lengerich, R., Binkley, P., Buchele, D., Anand, I., Swingen, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.547810 · Cited by 322
Wall, S. T., Walker, J. C., Healy, K. E., Ratcliffe, M. B., & Guccione, J. M. (2006) · Circulation · doi:10.1161/circulationaha.106.657270 · Cited by 312
Solomon, S. D., Skali, H., Anavekar, N. S., Bourgoun, M., Barvik, S., Ghali, J. K., Warnica, J. W., Khrakovskaya, M., Arnold, J. M. O., Schwartz, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508093 · Cited by 298
Self-citationAntiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation
Abraham, M. R., Henrikson, C. A., Tung, L., Chang, M. G., Aon, M., Xue, T., Li, R. A., O’ Rourke, B., & Marbán, E. (2005) · Circulation Research · doi:10.1161/01.res.0000174794.22491.a0 · Cited by 281
Hagège, A. A., Marolleau, J.-P., Vilquin, J.-T., Alhéritière, A., Peyrard, S., Duboc, D., Abergel, E., Messas, E., Mousseaux, E., Schwartz, K., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000521 · Cited by 277
Self-citationMyocyte and myogenic stem cell transplantation in the heart
Dowell, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00254-2 · Cited by 248
Solomon, S. D., Glynn, R. J., Greaves, S., Ajani, U., Rouleau, J.-L., Menapace, F., Arnold, J. M. O., Hennekens, C., & Pfeffer, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00009 · Cited by 214
Self-citationWebb, C. S., Bonnema, D. D., Ahmed, S. H., Leonardi, A. H., McClure, C. D., Clark, L. L., Stroud, R. E., Corn, W. C., Finklea, L., Zile, M. R., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.600353 · Cited by 202
Teng, C. J., Luo, J., Chiu, R. C. J., & Shum-Tim, D. (2006) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.05.034 · Cited by 192
Fukushima, S., Varela-Carver, A., Coppen, S. R., Yamahara, K., Felkin, L. E., Lee, J., Barton, P. J. R., Terracciano, C. M. N., Yacoub, M. H., & Suzuki, K. (2007) · Circulation · doi:10.1161/circulationaha.106.662577 · Cited by 180
Fernandes, S., Amirault, J.-C., Lande, G., Nguyen, J., Forest, V. F., Bignolais, O., Lamirault, G., Heudes, D., Orsonneau, J. L., Heymann, M., et al. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.003 · Cited by 140
Skeletal Myoblasts as a Therapeutic Agent
Menasché, P. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.02.002 · Cited by 137
Gavira, J. J., Herreros, J. M., Ruiz, A. P., et al. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.11.030 · Cited by 133
Tambara, K., Sakakibara, Y., Sakaguchi, G., Lu, F., Premaratne, G. U., Lin, X., Nishimura, K., & Komeda, M. (2003) · Circulation · doi:10.1161/01.cir.0000087430.17543.b8 · Cited by 130
Carluccio, E., Biagioli, P., Alunni, G., Murrone, A., Giombolini, C., Ragni, T., Marino, P. N., Reboldi, G., & Ambrosio, G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.064 · Cited by 122
Murtuza, B., Suzuki, K., Bou–Gharios, G., Beauchamp, J. R., Smolenski, R. T., Partridge, T. A., & Yacoub, M. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306205101 · Cited by 108
İnce, H., Petzsch, M., Rehders, T. C., Chatterjee, T. K., & Nienaber, C. A. (2004) · Journal of Endovascular Therapy · doi:10.1583/04-1386r.1 · Cited by 98
Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Death in Heart Failure
Stevenson, L. W. (2006) · Circulation · doi:10.1161/circulationaha.106.637405 · Cited by 72
Can Cold or Heat Shock Improve Skeletal Myoblast Engraftment in Infarcted Myocardium?
Ribes, A. M., Azarnoush, K., Sabbah, L., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000172178.35488.31 · Cited by 66
Cited by
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
The war against heart failure: the Lancet lecture
Braunwald, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61889-4 · Cited by 811
Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., Popescu, L. M., Torre, T., Siclari, F., Moccetti, T., & Vassalli, G. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu167 · Cited by 732
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Metadata
- Authors
- Menasché, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., Vilquin, J.-T., Marolleau, J.-P., Seymour, B., Larghero, J., Lake, S., Chatellier, G., Solomon, S., Desnos, M., & Hagège, A. A.
- Venue
- Circulation
- Published
- 2008-03-04
- Volume
- 117
- Issue
- 9
- Pages
- 1189-1200
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170871745
- Cited by
- 954
- References
- 31
- FWCI
- 41.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.